## CAH: Cardinal Health, Inc. - XLV: Healthcare

### Executive Summary

No thesis match: MRS_10 1.8% below STRENGTH zone (3.0-6.0%); PEG 1.88 fails VALUE criteria (<1.0). Stock is in no-man's land without clear edge.

- **Horizon:** N/A - no position
- **Risk Profile:** N/A - avoiding
- **Stop Type:** Fixed 2xATR ($195.62)
- **If Wrong:** N/A - wait for clearer setup
- **Invalidation:** MRS_10 falling below -5% or breaking key support

### News

- **Articles:** 10
- **Sentiment:** Bullish (Bullish: 3, Bearish: 0)

**1. Corient Private Wealth LLC Reduces Position in Cardinal Health, Inc. $CAH**
- Source: MarketBeat | 20251219T090742 | Somewhat-Bullish | Relevance: 100%
- Corient Private Wealth LLC decreased its stake in Cardinal Health, Inc. (NYSE:CAH) by 7.3% in the second quarter, now owning 81,436 shares valued at $13,681,000. This reduction comes amidst mixed activity from other institutional investors and several analyst upgrades for Cardinal Health, with a consensus "Moderate Buy" rating. The company recently reported strong quarterly earnings, beating analyst estimates, and declared a quarterly dividend.

**2. Has Cardinal Healthâ€™s 72.6% Surge Left Further Upside in 2025?**
- Source: Simply Wall Street | 20251219T040800 | Somewhat-Bullish | Relevance: 100%
- Cardinal Health's stock has surged significantly over the past year, leading to questions about its future upside. While a Discounted Cash Flow analysis suggests undervaluation, its Price-to-Earnings ratio indicates the stock is currently trading around its fair value compared to industry peers. Investors are encouraged to use "Narratives" for a more personalized valuation approach based on their own forecasts.

**3. Kwmg LLC Lowers Holdings in Cardinal Health, Inc. $CAH**
- Source: MarketBeat | 20251218T125659 | Bullish | Relevance: 100%
- Kwmg LLC reduced its stake in Cardinal Health, Inc. by 9.0% in Q3, selling 10,281 shares and now owning 103,812 shares valued at $16.29 million. Despite this, Cardinal Health exceeded Q3 earnings expectations with $2.55 EPS and $64.01 billion in revenue, leading to a "Moderate Buy" consensus rating and an average price target of $209 from analysts. The company also announced a quarterly dividend of $0.5107.

**4. Osaic Holdings Inc. Raises Stock Position in Cardinal Health, Inc. $CAH**
- Source: MarketBeat | 20251219T103411 | Bullish | Relevance: 100%
- Osaic Holdings Inc. increased its stake in Cardinal Health, Inc. by 25.6% during the second quarter, now holding 86,010 shares valued at $14.33 million. This increase precedes Cardinal Health's strong Q2 earnings, where it surpassed revenue and EPS expectations, and declared a quarterly dividend of $0.5107. Analysts maintain a "Moderate Buy" rating with a consensus price target of $209.00.

**5. Cardinal Health (CAH) Continues to Benefit from Rising Demand**
- Source: Insider Monkey | 20251219T062200 | Somewhat-Bullish | Relevance: 99%
- Cardinal Health (CAH) is benefiting from increasing demand for specialty and biologic therapies, as noted by Brown Advisory's Mid-Cap Growth Strategy. The company is expanding its value-added services, including in adjacent markets like third-party logistics and nuclear medicine, and its medical distribution business is showing improved margins. Despite having 55 hedge fund portfolios holding its stock, Cardinal Health is not among the 30 most popular stocks among hedge funds, and some AI stocks are considered to have greater promise for higher returns.

### Analyst Activity

**Target Signal:** NEUTRAL (Raises: 0, Lowers: 0)

| Date | Firm | Target | Prior | Change |
|------|------|--------|-------|--------|
| 2025-12-09 | Barclays | $243 | $0 | 0% |

**Rating Changes:**

| Date | Firm | Action | Grade |
|------|------|--------|-------|
| 2025-12-09 | Barclays | init | Overweight |

### Insider Activity (90 days)

| Metric | Value |
|--------|-------|
| Direction | **NET_SELLING** |
| Buys | 11 ($0.00M) |
| Sells | 5 ($0.41M) |

### Institutional Ownership

| Metric | Value |
|--------|-------|
| Total Ownership | 46.4% |
| Smart Money | **BULLISH** |
| Net Flow | 0.0% |
| Buying/Selling | 7 / 3 |

**Top Holders:**
- Blackrock Inc.: 13.2% (+3.0%)
- Vanguard Group Inc: 13.0% (+0.8%)
- State Street Corpora: 5.2% (-3.0%)
- Geode Capital Manage: 2.7% (+1.5%)
- Wellington Managemen: 2.4% (+153.2%)

### Key Risks

1. Market regime shift could impact momentum names disproportionately.
2. Sector rotation risk if leadership changes from current market theme.
3. Earnings execution risk on next quarterly report.

### Catalysts

- AI/machine learning initiatives could drive multiple expansion if executed.
- Broader market risk-on sentiment could lift quality names.

### Fundamentals

PEG ratio 1.88 elevated, pricing in significant growth expectations. Institutional flow bullish (7 buying vs 3 selling).

| Metric | Value |
|--------|-------|
| Market Cap | $48.2B |
| Beta | 0.64 |
| 52W Range | $116.03 - $214.93 |
| Short Interest | 3.1% |

| Valuation | Value |
|-----------|-------|
| PEG Ratio | 1.88 |
| Forward P/E | 18.3 |
| Current P/E | 20.6 |
| YoY Growth | 12.8% |
| EPS Direction | STABLE |

### Technicals

MRS_10 stable at 1.8% (minimal 5-day change). Below STRENGTH zone by 1.2pp (needs >3.0% for momentum thesis). MRS_5 at 0.4% confirms short-term momentum alignment. Long-term uptrend intact (above SMA200 at 1.27x) but short-term weakness (below SMA20). MACD histogram bearish (-1.23), momentum weakening. OFD pattern: +F0H (Breakout).

| Metric | Value | Signal |
|--------|-------|--------|
| MRS_10 | 1.80% (CS: 82) | Neutral |
| RSI_14 | 60.4 | Neutral |
| MACD Histogram | -1.23 | Bearish |
| vs SMA20 | 0.999x | Below |
| vs SMA50 | 1.068x | Above |
| vs SMA200 | 1.272x | Above |

### Decision

- **Verdict:** AVOID
- **Thesis:** NEUTRAL

### Trade Setup

- **Entry:** $202.90
- **Stop Loss:** $195.62 (3.6% risk)
- **Target:** $210.18 (R:R method)
- **Risk/Reward:** 1.00:1
- **Target Reasoning:** NEUTRAL thesis targets 1.0x risk/reward based on historical edge

### Position Sizing

- **Shares:** 164
- **Position Value:** $33,275.60
- **Portfolio %:** 33.28%
- **Risk Dollars:** $1,200.00
- **Risk Per Trade:** 1.20%
- **Modifiers:** L1 120% | L2 100% | Combined 1.20x

### Market Context

| Layer | Signal | Modifier |
|-------|--------|----------|
| L1 Macro | NORMAL (MEDIUM) | 1.20x |
| L2 Sector | NEUTRAL (Zone E) | 1.00x |

*NORMAL regime with improving risk appetite as VIX falls to 6th percentile and tech rally resumes on AI infrastructure demand. Fed pause expectations from cooling CPI data support equities, though elevated put/call ratio suggests cautious positioning. Focus on quality names in AI-exposed sectors.*

### Earnings

**Next:** 2026-01-29 (Est: $2.30)

| Quarter | Est | Actual | Surprise |
|---------|-----|--------|----------|
| 2025Q3 | $2.17 | $2.55 | +17.3% |
| 2025Q2 | $2.03 | $2.08 | +2.4% |
| 2025Q1 | $2.15 | $2.35 | +9.4% |
| 2024Q4 | $1.76 | $1.93 | +9.4% |

---
*RULE-based L3 | 2026-01-06 16:37 | MRS_10*